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Abstract
Homoisoflavonoids are rare compounds distributed within a few families of plants includ‐
ing species from Fabaceae. The genus Caesalpinia, the main focus of this chapter, is a prolific 
source of these unique natural products. Homoisoflavonoids from Caesalpinia spp. are associ‐
ated to ethnopharmacological uses for diverse purposes. In this sense, the following chapter 
sheds light on the occurrence, biosynthesis, isolation, synthesis, and structural analysis of 
these compounds from species of the genus Caesalpinia and their biological potential.
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1. Introduction
The genus Caesalpinia comprises more than 500 species around the world, existing essentially 
in tropical and subtropical zones. These species are correlated to ethnopharmacological uses 
due to their biological properties, which include analgesic, adaptogenic, antiangiogenic, 
antiulcer, anthelmintic, antibacterial, insecticidal, antifungal, anti‐inflammatory, antipyretic, 
antioxidant, antiproliferative, antiviral, antimalarial, immunomodulatory, and immunosup‐
pressive activities, as well as glutathione S‐transferase (GST) inhibition, xanthine oxidase 
(XO) inhibition suppression of melanin synthesis, inhibition of viral neuraminidases, and 
other properties which will be further discussed ahead [1–5].
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Associated to these biological properties, these plants are chemically composed by different 
classes of metabolites including steroids, organic acids, chromenes, diterpenes, triterpenes, 
polyphenols, tannins, anthraquinones, alkaloids, and flavonoids, which comprise the natural 
product diversity of this genus.
Besides these compounds, species from the genus Caesalpinia interestingly produce unusual 
compounds such as uncommon biflavonoids and a rare subclass of flavonoids, named homoi‐
soflavonoids. The first group is more distributed within plants, while homoisoflavonoids 
are restrict only to some vegetal species including those from Fabaceae and Asparagaceae 
[6]. These compounds are also encountered, although less common, in other families as 
Gentianaceae, Polygonaceae, Portulacaceae, and Orchidaceae. There are two different work 
concerning about homoisoflavonoids, which relate the existence of approximately 240 natu‐
rally occurring compounds [6, 7].
In this sense, it is important to define the general characteristics of flavonoids, once they are 
the core subunits of biflavonoids and cover the rare class of homoisoflavonoids. In general, 
flavonoids are low molecular weight polyphenols, brightly colored due to their absorptions 
of UV light, and the most common structures are associated to antioxidant properties [8–10]. 
Flavonoids, classified as phytoalexins, are produced as a response to microbial infection in 
plants. They have a notorious participation into the scientific scenario due to the beneficial 
association to the humans’ daily basis intake of nutrients as functional foods improving 
human health [8, 10].
The consumption of functional foods, or nutraceuticals, is strongly associated to these com‐
pounds. In addition, the ingestion of flavonoids from functional foods implicates in lowering 
blood triglycerides and homocysteine, decreasing blood pressure, acting against inflammatory, 
platelet antiaggregation processes, and the improvement of endothelial function [11]. These 
compounds are also associated to another range of biological properties lowering the incidence 
of cancer, including prostate, stomach, breast, and lung cancers [12]. In addition, various pro‐
tective effects of flavonoids have demonstrated them as important multi‐target agents [13, 14].
In that regard, the genus Caesalpinia is considered a rich source of common flavonoids. 
However, this genus is also associated to unique biflavonoids constituted by homoisofla‐
vonoids subunits and a considerable amount of representatives from the class of naturally 
occurring homoisoflavonoids. Up to date, there are reports pointing to the existence of about 
240 naturally occurring homoisoflavonoids [6, 7].
An interesting point is that homoisoflavonoids can also be found as dimers. Biflavonoids com‐
pounds are dimers of flavonoids assembled in diverse manners by different species. The number 
of possibilities for these structures (involving all classes of flavonoids) points to more than 20,000 
different molecules. However, not all these have been encountered in nature so far, summing to 
500 representatives [15]. From these, less than 10 are constituted by homoisoflavonoids subunits.
As homoisoflavonoids and their dimers from the genus Caesalpinia are unique compounds, 
this chapter proposes to gather the available data from the literature in a systematic overview 
associating them to biological properties aiming to demonstrate these compounds as notable 
representatives composing the chemical space associated to natural products.
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2. General classification and biosynthesis of flavonoids
The classification of flavonoids consists in two main groups, the 2‐phenylchromans and the 
3‐phenylchromans. Compounds presenting the 2‐phenylchroman core, in which the aromatic 
ring B is connected to C‐2 atom, include flavonols, flavanones, flavan‐3‐ols, flavones, antho‐
cyanins, and proanthocyanidins. On the other hand, compounds with the 3‐phenylchroman 
group, in which the aromatic ring B is connected to C‐3 atom, include isoflavonoids named 
isoflavones, isoflavans, and pterocarpans. Another group, named neoflavonoids, in which the 
benzene ring B is connected to C‐4 atom, is less common. There are cases in which the ring C 
occurs as an isomeric form presenting a five‐membered ring, which is associated to the forma‐
tion of aurones. Another class of phenolic compounds, named chalcones, is not considered 
true flavonoids due to their lack on the aromatic C ring but still considered members of the 
flavonoids family. In the same way, a closely related group compounds, the stilbenes, are 
important due to their biological potential [16]. A brief representation of each class of flavo‐
noids and their sources is demonstrated in Figure 1.
Figure 1. Classification of flavonoids, general structures, examples, and biological sources.
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These structures are important for the recognition and classification of biflavonoids moieties, 
once they could exist as complex structures presenting aurones, isoflavonoids, neoflavonoids, 
chalcones, and other moieties as well as dimers of homoisoflavonoids.
Flavonoids are products from the phenylpropanoid building block cinnamoyl‐CoA, in which 
chain extension is provided by three units of malonyl‐CoA [17]. Cinnamoyl‐CoA is derived 
from the amino acids phenylalanine and tyrosine which are converted by phenylalanine and 
tyrosine ammonia lyases to cinnamic acid and para‐hydroxycinamic acid, respectively [18]. 
The aromatic polyketide formed from the union of cinnamoyl‐CoA and three units of malonyl‐
CoA might form the benzo‐γ‐pyrone nucleus containing aromatic rings A, B, and a heterocy‐
clic ring C, substituted or not. This nucleus is precursor of a great number of flavonoids. In this 
sense, flavonoids are characterized by the classic flavan nucleus presenting a C
6
‐C
3
‐C
6
 skeleton. 
In addition, chalcones might undergo different cyclization with the addition of a single carbon, 
provided by S‐methyl moiety of methionine, which lead to the formation of the homoisofla‐
vonoid nucleus, which can be converted to the other classes of homoisoflavonoids (Figure 2).
Figure 2. Biosynthetic scheme for the formation of a flavonoid nucleus (monomeric structure of biflavonoids) and the 
formation of the existing types of homoisoflavonoid nucleus.
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3. Occurrence of homoisoflavonoids in Caesalpinia spp.
Homoisoflavonoids have a general structure of 16 carbons containing two phenyl rings and one 
heterocyclic ring. Homoisoflavonoids are biosynthesized from cinnamic acid derivatives along 
with malonyl‐CoA subunits. The resulting compound, an aromatic polyketide, is the precursor 
of chalcones. In the following step, the aromatic polyketide undergoes a Claisen and enoliza‐
tion reactions, which lead to the formation of the chalcone backbone. An additional carbon is 
added to the chalcone, provided by S‐methyl moiety from methionine, creating the homoisofla‐
vonoid skeleton containing 16 carbons. Thus, there is the formation of 3′‐hydroxyl‐chalcone as a 
precursor, which is transformed to 3‐benzylchroman‐4‐one. Subsequently, different cyclization 
leads to the formation of other types of homoisoflavonoids (Figure 2).
The existence of these compounds is associated to the genus Caesalpinia involving species 
as C. pulcherrima [19, 20], C. echinata [1, 21, 22], C. bonduc [3], C. sappan [4, 23–28], C. japonica 
[29], and C. milletti [30]. However, the diversity of compounds (in number and structurally) 
is associated to C. sappan, a prolific source of homoisoflavonoids with important ethnophar‐
macological applications. The crude extract of C. sappan, named Sappan lignum, is widely 
studied and used for the treatment of diverse diseases [28].
The classification of homoisoflavonoids comprises five main groups named scillascillin, bra‐
zilin, caesalpin, protosappanin, and sappanins. Homoisoflavonoids from the class scillascil‐
lins exhibit a spiro ring with four members between rings C and D. However, species from 
the genus Caesalpinia do not produce scillascillins. These compounds are encountered only in 
the family Asparagaceae [7].
The most common class of homoisoflavonoids in the genus Caesalpinia is the sappanin‐type. 
This class presents a 3‐benzyl chromanone unit. The diversity of these compounds is associated 
to a wide variation of substituents, such as hydroxyl, methoxyl, formyl, methyl groups, among 
others, which confer to sappanin‐type the position of the most abundant. In this chapter, the 
sappanin‐type homoisoflavonoids corresponded approximately to 70% of the compounds.
In this aspect, the species C. pulcherrima, which is a perennial large shrub,  widely distributed in 
the tropical and subtropical areas of Americas, South India, Taiwan and South‐East Asian coun‐
tries [20, 31]. It is used in the folk medicine due to its medicinal properties for the treatment of 
skin diseases, tumors, and fevers, and association to antibacterial, antidiarrheal, cytotoxic, and 
antiulcer properties [32]. C. pulcherrima produces a large variety of sappanin‐type homoiso‐
flavonoids exhibiting a diverse pattern of substitution such as bonducellin (1),  isobonducellin 
(2), 7‐O‐methylbonducellin (3),  2′‐O‐methylbonducellin (4),  sappanone A (5), (3E)‐3‐(1,3‐
benzodioxol‐5‐ylmethylene)‐2,3‐dihydro‐7‐hydroxy‐4H‐1‐benzopyran‐4‐one (6), (3E)‐3‐
(1,3‐benzodioxol‐5‐ylmethylene)‐2,3‐dihydro‐7‐methoxy‐4H‐1‐benzopyran‐4‐one 
(7), (E)‐3‐(3‐hydroxy‐4‐methoxybenzylidene)‐6,7‐dimethoxychroman‐4‐one (8), (3E)‐2,3‐
dihydro‐7‐hydroxy‐3‐[(3‐hydroxy‐4‐methoxyphenyl)‐methylene]‐4H‐1‐benzopyran‐4‐one 
(9), (3E)‐2,3‐dihydro‐3‐[(3,4‐dimethoxyphenyl)methylene]‐7‐methoxy‐4H‐1‐benzopyran‐4‐
one (10), (E)‐7‐methoxy‐3‐(4‐methoxybenzylidene)chroman‐4‐one (11), (E)‐7‐hydroxy‐3‐(3,4,5‐
trimethoxybenzylidene)chroman‐4‐one (12) [19, 20, 31]. Some of these compounds were 
tested against Gram‐positive microorganisms such as Bacillus subtilis, Bacillus sphaericus, and 
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Staphylococcus aureus exhibiting moderate antimicrobial activity. However, they were inactive or 
weakly active against Gram‐negative microorganisms such as Pseudomonas aeruginosa, Klebsiella 
aerogenes, and Chromobacterium violaceum. Concerning the antifungal activity, these compounds 
presented moderate activity against Aspergillus niger and Candida albicans in comparison with 
standard compounds Clotrimazole (antifungal), Streptomycin (antibacterial), and Penicillin 
G (antibacterial) [19]. Compounds 5 and 6 presented moderate activity against Staphylococcus 
aureus (inhibition zone of 11–15 cm) at 100 μg/mL, while 6 and 10 presented moderate activity 
against Klebsiella aerogenes (inhibition zone of 11–15 cm) at 100 μg/mL. Streptomycin presented 
an inhibition zone of 21–25 cm at 100 μg/mL. Compounds 5, 8, and 9 exhibited moderated 
activity against Aspergillus niger (inhibition zone of 5–10 cm at 150 μg/mL). On the other hand, 
the compounds 4, 8, 7, 9, and 10 were moderately active against Candida albicans at 150 μg/mL 
(inhibition zone of 5–10 cm). To comparison, positive control clotrimazole was active against all 
strains at 100 μg/mL (inhibition zone 21–25 cm) [19].
Rao and collaborators tested the compound 2 against the inflammatory process and described 
that 2 inhibits the production of NO, TNF‐α, and IL‐12. In fact, 2 was the most active com‐
pound in the experiments at the concentration of 40 μM, reducing 92% of the NO production 
(IC50 = 20 μM) in mouse peritoneal macrophages induced by LPS + IFN‐γ. The authors sug‐gested that the mode of action of 2 probably affects the production of NO by the induction of 
LPS + IFN‐γ in mouse peritoneal macrophages [20].
The species C. echinata, commonly known as Pau‐brasil (brazilwood), is endemic from Brazil 
and played an important historical role in the country [1]. This species has been reported 
to contain a large range of polyphenols including the homoisolflavonoids brazilin (13) and 
brazilin (14). The compound 15 is a natural dye and is also abundant in the species C. sappan 
(from 8 to 22%). The species C. echinata, considered the first source of brazilin, is used for 
diverse purposes such as healing agent, oral analgesic, and tonics. The species C. echinata 
has also demonstrated antitumor effect in vivo against cells strains of Ehrlich Carcinoma and 
Sarcoma 180. In addition, an interesting antiangiogenic effect was noticed [21]. On the other 
hand, compound 14, an oxidation product of brazilin, was considered effective against the 
inflammatory and cytotoxic processes [22]. Compound 14 displayed cytotoxic effects against 
human cancer cell lines, such as HepG2 and Hep3B (liver), MDA‐MB‐231 and MCF‐7 (breast), 
A549 (pulmonary), and CA9‐22 (gingival) [22].
Phytochemical studies on ethanolic extracts of C. bonduc yielded two sappanin‐type homoi‐
soflavonoids identified as caesalpinianone (15) and 6‐O‐methylcaesalpinianone (16), which 
exhibited different levels of GST inhibition and antifungal activities [3]. The IC50 values of compounds 15 and 16 were determined as 16.5 and 17.1 μM, respectively for GST inhibition. 
Ethacrynic acid, a standard substrate GST inhibitor, exhibited a IC50 = 17.6 μM, suggesting that homoisoflavonoids have significant inhibition of GST activity [3].
The species C. sappan is the most prolific source of homoisoflavonoids with many representa‐
tives involving brazilin‐, caesalpin‐, protosappanin‐ and sappanin‐types. Extracts of C. sappan, 
known as sappan lignum, have been used as emmenagogue, hemostatic, anti‐inflammatory 
and for treatment of thrombosis. There are also relates about its antimicrobial activity against 
Staphylococcus, Diplococcus, Corynebacterium, and Shigella baydii [24].The species C. sappan 
Flavonoids - From Biosynthesis to Human Health102
afforded brazilin‐ and sappanin‐types homoisoflavonoids such as compounds 13, 14, caesalpin P 
(17), 3′‐O‐methylbrazilin (18), brazilide A (19), 3′‐deoxy‐4‐O‐methylsappanol (20),  sappanol (21), 
4‐O‐methylsappanol (22, Figure 3), in which compounds 13, 14, and 20, and were active to the 
suppression of melan in synthesis [4]. Melanin is important to the protection of the skin from 
UV radiation, and its excessive synthesis could lead to melasma and lentigo. Compound 13 
exhibited strong suppression of melanogenesis (EC50 = 3.0 μM) and cell viability around 95%. Furthermore, compound 20 also exhibited expressive activity (EC50 = 4.6 μM) with nonsignificant toxicity (cell viability around 92%). The other compounds displayed high cytotoxicity against 
HMV‐II cells [4].
Species C. sappan constitute a source of sappanin‐type homoisoflavonoids.  Related compounds 
such as 4‐(7‐hydroxy‐2,2‐dimethyl‐9βH‐1,3,5‐trioxa‐cyclopenta[α]naphthalene‐3‐lymethyl)‐ben‐
zene‐1,2‐diol (23), 7,3′,4′‐trihydroxy‐3‐benzyl‐2H‐chromene (24) exhibited moderate activity as 
inhibitors of viral neuraminidases. Viral neuraminidases are considered essential to viral repli‐
cation cycle and a valid therapeutic target for antiviral drugs. Compound 5 presented the best 
activity against H1N1 (IC50 = 0.7 μM); H3N2 (IC50 = 1.1 μM); and H9N2 (IC50 = 1.0 μM) [23].
Figure 3. Sappanin‐type and brazilin‐type homoisoflavonoids from Caesalpinia spp.
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Other sappanin‐type compounds such as (3R,4S)‐3‐(4′‐hydroxybenzyl)‐3,4‐dihydro‐2″,3″‐
dimethyl‐3H‐[1,3]dioxolo[4,5‐c]chromen‐7‐ol (25), and (3aR,9bS)‐3a‐(4‐hydroxy‐3‐methoxy‐
benzyl)‐2,2‐dimethyl‐4,9b‐dihydro‐3aH‐[1,3]dioxolo[4,5‐c]chromen‐7‐ol (26) are associated 
to the inhibition of NO production [27]; 21 and 22 associated to the inhibition of melanin 
synthesis [4]. Sappanol derivatives were also identified from C. sappan as in the case of 3′‐O‐
methylsappanol (27), 3′‐O‐methylepisappanol (28), and a unique lactone‐based homoisofla‐
vonoid named caesalpiniaphenol B (29) [6]. In addition, the compound caesalpin J (30), one 
of the only seven caesalpin‐type homoisoflavonoids reported in the literature, was isolated 
from C. sappan. Caesalpin J exhibited weak to moderate antimicrobial effects [25].
The species C. japonica is considered another source of biologically active homoisoflavonoids 
in which diverse homoisoflavonoids including 5, 13, 20, 21, 22, protosappanin A‐C (31–33), 
4‐O‐methylepisappanol (34), episappanol (35), and sappanone B (36, Figures 4–6) have been 
isolated and characterized [29].
Figure 4. Sappanin‐, casealpin‐, and protosappanin‐type structures of homoisoflavonoids from Caesalpinia spp.
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Figure 5. Bihomoisoflavonoids from species of the genus Caesalpinia.
Figure 6. Scheme of synthesis of sappanin‐type homoisoflavonoids obtained from C. pulcherrima. Reagent and conditions: 
(i) CH
3
I, K2CO3, acetone, 2h, reflux, (91%); (ii) substituted benzaldehyde, piperidine, 2h (58–69%). Adapted from Ref. [19].
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Homoisoflavonoids classified as protosappanins are commonly associated to the species C. 
sappan and C. japonica. These compounds are resulting from the connection of C‐4 and C‐4a 
atoms forming an eight‐membered ring. There are only eleven protosappanins reported so far 
[26]. Compounds 31–33 did not show significant cytotoxicity against MCF7, A549, LN229 cell 
lines. In addition, compounds 32 and 33 were also tested against the inflammatory process 
exhibiting weak to moderate activity [27].
4. Biflavonoids containing homoisoflavonoids subunits in Caesalpinia 
spp.
Flavonoids can also exist as dimers, named biflavonoids, which represents flavonoids linked 
by C–C or C–O–C bond in order to form a flavonoid‐flavonoid structure. The connection can 
occur in several modes in the three rings of the flavan nucleus. The ring A could be linked to 
the ring A′, indicated as A‐A. This could also occur between the rings A‐C, B‐B, C‐B, among 
other possibilities that are enlarged by functional groups as OH, MeO, C═O, C═C. The occur‐
rence of common biflavonoids in the genus Caesalpinia is known only to some species, such as 
C. ferrea [33], C. pyramidalis [34], C. pluviosa [35].
Furthermore, certain species from the Caesalpinia, mostly C. sappan, are associated to the pro‐
duction of biflavonoids containing homoisoflavonoids subunits such as protosappanin D (37), 
a biflavonoid which exhibit two subunits of 33, and protosappanin E (38), which display 13 
and 33 as subunits. Compounds 37 and 38 were tested against the inflammatory process asso‐
ciated to the inhibition of iNOS and PGE2 production, as well as the suppression of TNF‐α 
and COX‐2. Washiyama and collaborators suggested that the protosappanin skeleton and the 
functional group at C7 would be important to the activity of 37 and 38 [27]. The investigation of 
sappan lignum as a possible XO inhibitor leads to the isolation of diverse compounds including 
neoprotosappanin (39) and protosappanin E‐2 (40, Figure 5). These two compounds presented 
IC50 of 38.3 and 18.9 μM, respectively, exhibiting a concentration‐dependent behavior. In what extent their mode of inhibition, the biflavonoid 39 was considered a noncompetitive XO inhibi‐
tor while 40, a competitive inhibitor [2]. The inhibition of XO is associated to improvements in 
cardiovascular health as well as, the reduction of ROS, and the amelioration of gout cases [36].
The presence of rare caesalpins is correlated to C. sappan. A dimer named neosappanone 
(41) was isolated from this species and evaluated against XO. The IC50 of 41 was determined as 29.7 μM and associated to a competitive inhibition of XO. Therefore, these results showed 
that the traditional use of C. sappan for rheumatism and inflammatory diseases could be 
attributed to its phenolic composition, specifically to dimers of homoisoflavonoids [2].
5. Isolation, synthesis, and structural analysis of homoisoflavonoids
Due to the intrinsic interest in homoisoflavonoids and their biological activities, several 
works have been discussing different structural aspects of homoisoflavan nucleus‐bearing 
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organic compounds [6, 7]. The structural uniqueness of these compounds and their potent 
biological activities makes them a target of choice for studies in natural products research 
on the determination of absolute configurations, organic synthesis, isolation, and structural 
determination [7].
The isolation of homoisoflavonoids involves different chromatographic techniques. Homo‐
isoflavonoids are generally separated after treatment of the organic extract (MeOH, CHCl
3
) 
with several chromatographic phases. The use of column chromatography steps (using silica 
gel and/or Sephadex LH‐20), preparative thin layer chromatography, as well as high per‐
formance liquid chromatography (HPLC) methods (semi‐preparative and preparative) have 
been used to purification [7]. In addition, there are other methods used to the isolation of 
flavonoids, such as counter current chromatography [37] can be adopted for the isolation of 
homoisoflavonoids and flavonoids.
Besides the isolation of naturally occurring homoisoflavonoids from the species C. pulcherrima, 
a synthetic approach of the isolated homoisoflavonoids 1, 3, 4, 5, 6, 7, 9, and 10 employed the 
piperidine catalyzed condensation as key steps in this synthesis of these structures (Figure 6). 
This procedure afforded products reaching around 60% yielding following conditions exhib‐
ited in Figure 3 [19].
The structures of homoisoflavonoids have been unambiguously established by analysis of 
spectroscopic NMR data supported by analysis of UV and MS spectra. These analyses con‐
firm the presence of the 15‐carbon backbone related to classic flavonoids, and the 16‐carbon 
skeleton with two phenyl rings (A and C) and one heterocyclic ring (B) separated by an addi‐
tional carbon, forming the homoisoflavonoids skeleton [24, 29, 31].
Analysis of the 1H and 13C NMR spectra indicates the presence of carbonyl groups at δC 170.7–220.0 as well as those assigned to carbons/hydrogens of aromatic ring at δC 100.0–170.0/δH 6.00–8.50 and hydroxyl derivate group as characteristic signs. The homoisoflavonoids, when 
existing as dimers, exhibited their 13C and 1H NMR spectra typically duplicate and super‐
posed when presenting the same subunits.
The extra carbon existing in homoisoflavonoids compared to ordinary  flavonoids  can be ali‐
phatic displaying 13C and 1H NMR signs at δC 30.0–35.0/δH 2.60–3.00; or olefinic at δC  100.0–140.0/δH 5.30–6.00, respectively. Correlations in the HMBC, HSQC and COSY spectrum resolve all ambi‐
guities to the structure of these compounds.
The compounds 17, 19, 29, 37, 38 are homoisoflavonoids derived from the auto‐oxidation 
of precursors or present differentiated biosynthesis. These compounds present uncommon 
chemical structures with 1H, and 13C NMR spectra relativity complex, in some cases, exhibit‐
ing signs that indicate the presence of lactone and others characteristic group.
Homoisoflavonoids present signals of absorptions in the UV spectrum at λmax 222–230, 270–280, and 300–310 nm, depending on the presence of conjugated double bonds on their structures. 
The MS spectrum present [M+H]+ ions between m/z 250–350 to homoisoflavonoids and [M+H]+ 
ions between m/z 500–600 to dimers of homoisofavonoids with some minor compounds with 
m/z > 600 [24, 29, 31].
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The absolute stereochemistry can be established by circular dichroism analysis by compari‐
son to models with known stereochemistry. The compound 28, isolated from C. sappan, had its 
absolute stereochemistry determined by this method compared with data from 3‐deoxysap‐
panol. The result suggested that 28 has the absolute stereochemistry at the C‐3 and C‐4 posi‐
tions to be (3R,4S) [24].
6. Conclusion
The chemical space related to natural products is associated to important scientific findings 
in what to extent the discovery of important new chemical entities. In this sense, the genus 
Caesalpinia is a prolific source of secondary metabolites which also biosynthesize homoisofla‐
vonoids. In addition, only a few species are reported to produce dimers of homoisoflavonoids 
as secondary metabolites. Homoisoflavonoids and its dimers are classified as unusual natural 
products with strict occurrence in nature present the most diverse types of biological activities. 
These compounds are isolated through HPLC methods and identified by different techniques 
as NMR, UV, MS based on the biosynthesis of chalcones with an additional carbon provided 
by S‐methyl from methionine. It is important to highlight that these phenolic compounds are 
part of ethnopharmacological applications by people whose access and use the biodiversity 
for the improvement of health conditions are made for centuries. Furthermore, the investiga‐
tion of this class of phenolic compounds provides chemosystematics data for classification 
and discovery of pharmacologically efficient compounds from species of Caesalpinia spp.
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